104 related articles for article (PubMed ID: 28152354)
21. Cervical cancer in women under 25 years of age in Queensland, Australia: To what extent is the diagnosis made by screening cytology?
Morgan EL; Sanday K; Budd A; Hammond IG; Nicklin J
Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):469-472. PubMed ID: 28580578
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with cancer-specific and overall survival among Indigenous and non-Indigenous gynecologic cancer patients in Queensland, Australia: a matched cohort study.
Diaz A; Moore SP; Martin JH; Green AC; Garvey G; Valery PC
Int J Gynecol Cancer; 2015 Mar; 25(3):542-7. PubMed ID: 25700033
[TBL] [Abstract][Full Text] [Related]
23. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
Soccio J; Brown M; Comino E; Friesen E
J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
[TBL] [Abstract][Full Text] [Related]
24. Risk of cervical cancer after a negative Pap smear.
Viikki M; Pukkala E; Hakama M
J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
[TBL] [Abstract][Full Text] [Related]
25. The Fitzroy Valley Pap Smear Register. Cervical screening in a population of Australian aboriginal women.
Mak DB; Straton JA
Med J Aust; 1993 Feb; 158(3):163-6. PubMed ID: 8450781
[TBL] [Abstract][Full Text] [Related]
26. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States.
Rahangdale L; Sarnquist C; Yavari A; Blumenthal P; Israelski D
J Womens Health (Larchmt); 2010 Apr; 19(4):709-12. PubMed ID: 20201703
[TBL] [Abstract][Full Text] [Related]
27. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
29. Breast and cervical cancer screening in obese minority women.
Ferrante JM; Chen PH; Jacobs A
J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
[TBL] [Abstract][Full Text] [Related]
30. Papanicolaou smear screening of women with intellectual disabilities: a cross-sectional survey in Taiwan.
Lin LP; Lin JD; Sung CL; Liu TW; Liu YL; Chen LM; Chu CM
Res Dev Disabil; 2010; 31(2):403-9. PubMed ID: 19897337
[TBL] [Abstract][Full Text] [Related]
31. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
Sirovich BE; Gottlieb DJ; Fisher ES
J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
[TBL] [Abstract][Full Text] [Related]
32. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
33. How well is the National Cervical Screening Program performing for Indigenous Australian women? Why we don't really know, and what we can and should do about it.
Whop LJ; Cunningham J; Condon JR
Eur J Cancer Care (Engl); 2014 Nov; 23(6):716-20. PubMed ID: 25238027
[TBL] [Abstract][Full Text] [Related]
34. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
35. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
Budge M; Halford J; Haran M; Mein J; Wright G
Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
[TBL] [Abstract][Full Text] [Related]
36. Pap test use and cervical cancer incidence in First Nations women living in Manitoba.
Decker KM; Demers AA; Kliewer EV; Biswanger N; Musto G; Elias B; Griffith J; Turner D
Cancer Prev Res (Phila); 2015 Jan; 8(1):49-55. PubMed ID: 25403849
[TBL] [Abstract][Full Text] [Related]
37. Use of and attitudes and knowledge about pap smears among women in Kuwait.
El-Hammasi K; Samir O; Kettaneh S; Al-Fadli A; Thalib L
J Womens Health (Larchmt); 2009 Nov; 18(11):1825-32. PubMed ID: 19951218
[TBL] [Abstract][Full Text] [Related]
38. Limited Pap screening associated with reduced risk of cervical cancer in South Africa.
Hoffman M; Cooper D; Carrara H; Rosenberg L; Kelly J; Stander I; Williamson AL; Denny L; du Toit G; Shapiro S
Int J Epidemiol; 2003 Aug; 32(4):573-7. PubMed ID: 12913031
[TBL] [Abstract][Full Text] [Related]
39. Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study.
Nieminen P; Kallio M; Anttila A; Hakama M
Int J Cancer; 1999 Sep; 83(1):55-8. PubMed ID: 10449608
[TBL] [Abstract][Full Text] [Related]
40. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
Açikgöz A; Ergör G
Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
